Abdelhak, A., Hottenrott, T., Morenas-Rodríguez, E., Suárez-Calvet, M., Zettl, U. K., Haass, C., . . . Huss, A. (2019). Glial Activation Markers in CSF and Serum From Patients With Primary Progressive Multiple Sclerosis: Potential of Serum GFAP as Disease Severity Marker? Front Neurol.
Chicago Stili AlıntıAbdelhak, Ahmed, et al. "Glial Activation Markers in CSF and Serum From Patients With Primary Progressive Multiple Sclerosis: Potential of Serum GFAP As Disease Severity Marker?" Front Neurol 2019.
MLA AlıntıAbdelhak, Ahmed, et al. "Glial Activation Markers in CSF and Serum From Patients With Primary Progressive Multiple Sclerosis: Potential of Serum GFAP As Disease Severity Marker?" Front Neurol 2019.
Uyarı: Bu alıntı herzaman %100 doğru olmayabilir..